India’s benchmark Nifty 50 index will see InterGlobe Aviation (IndiGo) and Max Healthcare replace IndusInd Bank and Hero MotoCorp, effective September 30, 2025, following NSE’s semi-annual reshuffle driven by free-float market capitalization.

India’s equity markets are likely to experience a major transformation as the Nifty 50 index will be joined by InterGlobe Aviation Ltd., the company operating the IndiGo airline, and Max Healthcare Institute from September 30, 2025. These get-ons board are a part of the National Stock Exchange’s biannual shuffle, leading to the replacement of IndusInd Bank and Hero MotoCorp in the benchmark index.

Market Reshuffle and Capitalization Insights

The step is motivated by an elevated six-month average free-float market capitalization. The free-float market cap of IndiGo is USD 13.7 billion, while that of Max Healthcare is USD 10.2 billion. Conversely, IndusInd Bank and Hero MotoCorp, which have lower averages of USD 6.6 billion and USD 6.3 billion, respectively, will move to the Nifty Midcap Select index.

Analysts are pointing out that reshuffles of this magnitude generally cause large-scale changes in exchange-traded funds (ETFs) which are tracking the index. Passive investors will buy millions of dollars worth of shares due to stocks entering the index. It is expected to happen in the case of IndiGo and Max Healthcare. The reason for that is the aviation industry and healthcare sectors are the most promising in India and are showing excellent structural growth potential.

Also Read: Everything You Need to Know About IndusInd Bank’s New CEO

Sectoral and Stock Performance

Among India’s stocks, IndiGo has been the most outstanding in 2025 as its price skyrocketed more than 32% since the beginning of the year. The company is powered by strong demand for air travel and has also been able to widen its international flights although the rising operational cost is a matter of concern. Max Healthcare, on the other hand, is making steady progress, with the increase in the spending on health and the efficient utilization of the hospitals’ capacity being the major contributing factors.

On the contrary, IndusInd Bank is the story of a downfall as it has had a hard time and the share value has decreased significantly as a result of internal financial missteps and the subsequent resignation of the management team earlier this year. Hero MotoCorp, albeit being on the safe side, has neither managed to keep pace with the technology trend nor has it been able to leverage strong growth in India’s high-momentum sectors such as aviation and healthcare.

Broader Market Impact

The coming of IndiGo and Max Healthcare makes the consumer-focused and healthcare-driven sectors more prominent players in India’s capital markets. Analysts view this trend as being backed by the strength of the consumption-driven economy in India which makes the representation of these sectors continue to rise.

Moreover, these adjustments have been also made beyond the Nifty 50, affecting other indices, such as Nifty 100, Nifty Next 50, Nifty 500, Midcap, and Smallcap, whereas sectoral indices, e.g., Bank, IT, FMCG, and Oil & Gas, receive no changes.

This reshuffle will have its impact from September 30, 2025, which is in line with NSE’s methodology of checking free-float market capitalization over two six-month periods ended on January 31 and July 31.

Investor Outlook

The reshuffle is a dual signal to investors about sector rotation and the long-term changes in market leaders. The integration of IndiGo and Max Healthcare into the most followed Indian index only confirms the investors’ hunger for high-growth sectors while giving the departing stocks, which mostly consist of under-performing companies, a warning that they should be avoided.

READ MORE ON

Read the full article here: NSE Confirms IndiGo and Max Healthcare’s Entry into Nifty 50 — For more updates, visit Wittiya – Top Business News, Stock Market Insights & Financial Updates (Wittiya).

Indian equity markets are set to open on a positive note on Monday, August 25, 2025, tracking strong global cues after US Federal Reserve Chair Jerome Powell hinted at a potential interest rate cut. Several key companies, including Reliance Industries, IndiGo, Max Healthcare, Yes Bank, and IDBI Bank, will remain in focus during today’s trading session.

Indian stock markets are expected to begin the week on a stronger footing, supported by global momentum. At 7:56 AM, GIFT Nifty futures traded at 24,955, up 57 points, signaling a likely positive opening for benchmark indices.

Across the Asia-Pacific region, markets reflected the optimism seen on Wall Street, where the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite closed sharply higher. The gains were triggered after US Federal Reserve Chair Jerome Powell, speaking at the Jackson Hole Symposium in Wyoming, indicated that an interest rate cut could be considered as early as next month.

Asian markets followed suit: Japan’s Nikkei 225 advanced 1.08%, South Korea’s Kospi rose 0.75%, Australia’s S&P/ASX 200 gained 0.87%, while China’s Shanghai Composite moved up 0.64%. Investors also await Singapore’s Consumer Price Index (CPI) data for July to gauge regional inflation trends.

Stocks to Watch Today

• Nifty50 Rejig:

InterGlobe Aviation (IndiGo) and Max Healthcare Institute are set to replace Hero MotoCorp and IndusInd Bank in the Nifty 50 index, effective September 30, 2025. The reshuffle positions aviation and healthcare as growing segments in the benchmark index.

• Yes Bank:

Sumitomo Mitsui Banking Corporation (SMBC) has received approval from the Reserve Bank of India (RBI) to acquire up to 24.99% equity stake in Yes Bank. The approval is valid for one year, though RBI clarified that SMBC will not be classified as a promoter. This move could strengthen Yes Bank’s capital base and enhance global strategic partnerships.

• Reliance Industries (RIL):

Mumbai-headquartered Reliance Industries Limited (RIL) announced that its step-down wholly owned subsidiary, Nauyaan Tradings Private Limited (NTPL), has acquired the remaining 6.1% equity in Nauyaan Shipyard Private Limited (NSPL) from Welspun Corp for ₹45.32 crore. With this acquisition, NSPL becomes a full step-down subsidiary, further expanding RIL’s presence in shipbuilding and infrastructure.

• Titagarh Rail Systems:

Kolkata-based Titagarh Rail Systems has secured a Letter of Acceptance from Banaras Locomotive Works for the complete shell assembly of WAG-9HC locomotives. The order, valued at ₹91.12 crore (including GST), strengthens Titagarh’s position in India’s fast-growing railway manufacturing sector.

Also Read: Market Rally Unveils Big Winners – 8 Stocks at Their Strongest Levels in a Year

• Brigade Enterprises:

Bengaluru-based Brigade Enterprises launched “Brigade Lakecrest”, a premium residential project near Bhattarahalli Lake on Old Madras Road. Developed under a joint development model, the project spans 9.33 lakh sq. ft. and is expected to generate revenues exceeding ₹950 crore.

• IDBI Bank:

IDBI Bank announced that SEBI has approved the reclassification of Life Insurance Corporation of India (LIC) as a public shareholder rather than a promoter. This move is subject to specific conditions and is a significant step in IDBI’s transition towards privatization.

• RailTel Corporation of India:

RailTel has received a work order worth ₹13.16 crore (including taxes) from the Rajasthan Skill & Livelihoods Development Corporation (RSLDC) to provide project management consultancy (PMC) services.

• Interarch Building Solutions:

Interarch Building Solutions secured a ₹90 crore order from Rungta Mines Limited for designing, engineering, manufacturing, and erecting a pre-engineered steel building system.

• IndusInd Bank:

IndusInd Bank saw its credit rating affirmed at CRISIL AA+ with a Negative outlook by CRISIL Ratings, while also being removed from the “watch with negative implications” list.

• Akums Drugs and Pharmaceuticals:

Akums Drugs signed a Framework Agreement with the Government of the Republic of Zambia on August 22, 2025, to establish a local pharmaceutical manufacturing facility. The project aims to support Zambia’s national healthcare programs while boosting local production capacity.

• Eris Lifesciences:

Eris Lifesciences disclosed that it has received a show cause-cum-demand notice from the Directorate General of GST Intelligence (DGGI), Mumbai, regarding alleged non-payment of IGST under the reverse charge mechanism for import of services.

READ MORE ON

Read the full article here: Nifty Rejig, RBI Nod, Big Acquisitions: Stocks to Track on August 25 — For more updates, visit Wittiya – Top Business News, Stock Market Insights & Financial Updates (Wittiya).

Axis Securities has released its July stock picks for India, highlighting promising mid-cap and small-cap companies such as Lupin, Max Healthcare, and Kalpataru Projects. The brokerage sees strong upside driven by recovering market trends, better earnings visibility, and domestic macroeconomic stability.

Mumbai-based Axis Securities, a subsidiary of Axis Bank and a prominent brokerage house in India, has released its list of recommended mid-cap and small-cap stocks for July 2025, highlighting growth potential across various sectors as the domestic market continues to recover.

According to Axis Securities, the Indian stock market has shown steady signs of recovery since March 2025. The Nifty 50 has climbed 15%, while the Mid-Cap and Small-Cap indices have surged 25% and 29% respectively since the lows of February. In June alone, the Small-Cap index rose by 5.7%, the Mid-Cap by 4%, and the Nifty 50 by 3.1%.

Axis Securities emphasized that the current risk-reward profile favors mid and small-cap stocks. The brokerage is focusing on companies with strong earnings visibility, quality business models, and exposure to domestic consumption.

Top Picks for July:

• Lupin Ltd (CMP: ₹1,938; Target: ₹2,500)
  Lupin, a global pharmaceutical company headquartered in Mumbai, is expected to benefit from recent product launches in complex generics. Products like Darunavir and Spiriva have captured significant market share in the US. The company is also set to benefit from new introductions such as Tolvaptan and Xyway.
  
• Max Healthcare Institute Ltd (CMP: ₹1,276; Target: ₹1,450)
  Max Healthcare, a leading healthcare provider in India, is witnessing consistent growth in its institutional and international patient segments. Margin pressures from new hospitals are expected to ease with operational scaling.
  
• Colgate-Palmolive (India) Ltd (CMP: ₹2,407; Target: ₹2,830)
  Colgate is focusing on premium product launches and rural penetration. The firm’s long-term strategy and attractive valuation post recent price corrections make it a solid defensive pick.
  
• Prestige Estates Projects Ltd (CMP: ₹1,657; Target: ₹1,900)
  Prestige Estates, a major real estate developer, plans new project launches worth ₹42,000 crore in FY26, aiming to drive a 65% YoY increase in pre-sales despite underperformance in FY25 due to regulatory delays.
  
• APL Apollo Tubes Ltd (CMP: ₹1,739; Target: ₹2,035)
  APL Apollo, a steel product manufacturer, plans to scale capacity to 10 million tonnes per annum by FY30. It trades at a 38x forward P/E with a long-term growth focus.
  
• Kalpataru Projects International Ltd (CMP: ₹1,227; Target: ₹1,350)
  Kalpataru, operating in engineering and infrastructure, is expected to see strong revenue growth on the back of a healthy order book and better performance from international subsidiaries.
  
• Sansera Engineering Ltd (CMP: ₹1,380; Target: ₹1,580)
  Sansera, a precision component manufacturer, is set to grow its revenue and profitability due to its shift towards premium non-auto products and increased operating efficiency.
  

Axis Securities believes the current market environment provides a conducive backdrop for these stocks, especially as India approaches FY26 with improved earnings outlook and favorable macroeconomic indicators.

Read the full article here: India’s Stock Market Awakens: The July Power Portfolio — For more updates, visit Wittiya – Top Business News, Stock Market Insights & Financial Updates (Wittiya).